Which is more profitable, Merck & or Vertex Pharmaceuticals?

Vertex Pharmaceuticals keeps more of every sale as profit.

Which grows faster, Merck & or Vertex Pharmaceuticals?

Vertex Pharmaceuticals grew its sales faster in recent years.

Which is cheaper, Merck & or Vertex Pharmaceuticals?

Merck & costs less for each unit of yearly profit (lower P/E).

Which has less debt, Merck & or Vertex Pharmaceuticals?

Vertex Pharmaceuticals would need fewer years of earnings to pay off its debt.

Merck &MRKvs

Vertex PharmaceuticalsVRTX

Merck & vs Vertex Pharmaceuticals stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Merck & is cheaper for its profits. Vertex Pharmaceuticals is more profitable, grows faster and has less debt.

Side by side

	Merck &	Vertex Pharmaceuticals
	$364 billion	$137 billion
	28.1%	32.9%
	+9.4%	+14.1%
	20.0×	34.5×
	1.2 years	Net cash
	17.8%	18.2%
	2.8%	–

Open Merck &Open Vertex Pharmaceuticals

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Merck & vs AbbVie · Merck & vs Amgen · Merck & vs argenx · Merck & vs Bayer · Vertex Pharmaceuticals vs Roche · Vertex Pharmaceuticals vs UnitedHealth · Vertex Pharmaceuticals vs AbbVie · Vertex Pharmaceuticals vs Johnson & Johnson